Risk Alerts
Date | Name | Format | Download |
---|---|---|---|
09/20/23 | Risk Alert - FDA Approves Updated COVID Vaccines, CDC Provides Recommendations Regarding Recipients |
||
09/07/23 | Risk Alert - Updated Guidelines for 2023-2024 Flu Vaccine and Current Provider Requirements when Administering Vaccines |
||
06/21/23 | Risk Alert: US Food & Drug Administration Issues Warning Regarding Compounding Semaglutides |
||
06/15/23 | Risk Alert - New Jersey Executive Order Lifts COVID-19 Vaccination Requirement for Healthcare Settings |
||
06/13/23 | Risk Alert: Fraud Targeting Insureds Making Online Payments |
||
05/18/23 | Risk Alert: Have You Heard? There Are New Eight-Hour Training Requirements For DEA-Registered Prescribers |
||
05/11/23 | Risk Alert: End of COVID-19 Public Health Emergency (PHE) |
||
05/04/23 | Risk Alert: New Jersey Attorney General Directive Regarding Statements on Use of Mifepristone |
||
03/09/23 | Risk Alert - COVID-19 Public Health Emergency Ends May 11, 2023 |
||
01/30/23 | Risk Alert - Fraudulent Nursing Diplomas Issued From Three Florida Nursing Schools |
||
12/22/22 | Electronic Prescribing for Controlled Substances (EPCS) – Effective January 2023 |
||
10/19/22 | Risk Alert - Scammers at Work as Federal Student Loan Forgiveness Application Opens |
||
09/02/22 | Risk Alert - Monkeypox (hMPXV) and Polio Information Available |
||
08/15/22 | Risk Alert - Warning! Telephone Scams Targeting Providers Increasing |
||
08/02/22 | Risk Alert - Monkeypox Information Available |
||
07/27/22 | Risk Alert - Office of Inspector General Issues Warning Regarding Telehealth Companies and Efforts to Thwart Fraud Committed by Vendors and Providers |
||
07/25/22 | Risk Alert - Temporary Emergency Reciprocity License Program Discontinued |
||
04/21/22 | Risk Alert - COVID-19 Vaccine Requirements for Healthcare Workers Clarified |
||
03/16/22 | Risk Alert - Governor Murphy Signs Executive Order Terminating the COVID-19 Public Health Emergency, Other Executive Orders Remain in Effect |
||
03/07/22 | Risk Alert - CMS Reopens the MIPS EUC Application for the 2021 Performance Year for Eligible Groups |
||
03/04/22 | Risk Alert - COVID-19 “Up to Date“ Vaccine Status Deadline Extended for Healthcare Workers |
||
01/20/22 | Risk Alert - U.S. Supreme Court & New Jersey Governor Issue Ruling & Executive Order on COVID-19 Vaccine Mandates |
||
01/14/22 | Risk Alert - Governor Murphy Reinstates a Public Health Emergency in Response to Omicron Variant of COVID-19 |
||
01/14/22 | Risk Alert - COVID-19 CDC Vaccine, Booster, and Quarantine Updates |
||
11/01/21 | Risk Alert - Clarification Regarding Mandatory Covid-19 Vaccination and Testing Reporting by Physician Offices |
||
10/19/21 | Risk Alert - Mandatory Vaccination and Testing Documentation and Reporting Required – New Jersey Department of Health |
||
09/23/21 | Risk Alert - Warning about Telephone Fraud Targeting Providers |
||
09/17/21 | Risk Alert - HRSA Announces Additional $25.5 Billion in Provider COVID-19 Relief Funds |
||
09/10/21 | Risk Alert - Federal and New Jersey COVID-19 Vaccination Requirements for Healthcare Workers |
||
08/03/21 | Risk Alert - Governor Murphy Announces Vaccine Requirement for Workers in Health Care Facilities and High-Risk Congregate Settings |
||
07/22/21 | Risk Alert - Ivermectin to Prevent/Treat COVID-19 Study Retracted Amid Ethical Concerns |
||
06/29/21 | Risk Alert - New Requirements For COVID-19 Testing Before Surgery |
||
06/24/21 | Risk Alert - Medicare Administrative Contractors (MACs) Increasing Post-Payment Medical Reviews |
||
06/22/21 | Risk Alert - New OSHA COVID-19 Standards Apply To Physician Offices |
||
06/21/21 | Risk Alert - Changes to New Jersey Provider Immunity as Public Health Emergency Ends: Effective July 4, 2021 |
||
06/14/21 | Risk Alert - New Jersey Healthcare Transparency Act: Effective July 1, 2021 |
||
05/12/21 | Risk Alert - Cyber Security Breaches in Physician Offices Soar |
||
07/01/20 | Risk Alert - MIPS 2020 Extreme and Uncontrollable Circumstances Application |
||
06/09/20 | Risk Alert - Requirement During COVID-19: Prescription of Naloxone with Opioid |
||
05/21/20 | Risk Alert - New Guidance on Elective Surgeries and Procedures |
||
03/27/20 | Risk Alert - Coronavirus Aid, Relief, and Economic Security (CARES) Act |
||
03/05/20 | Risk Alert - COVID-19: Preparation for Medical Offices |
||
01/24/20 | Risk Alert - 2019 Novel Coronavirus: Interim Guide for Healthcare Professionals |
||
12/14/19 | Risk Alert-2019 MIPS Final Eligibility and New Medicare Card |
||
08/30/19 | Risk Alert-Aid in Dying Act Temporary Restraining Order Lifted |
||
08/02/19 | Risk Alert-Aid in Dying Act Temporary Restraining Order |
||
07/30/19 | Risk Alert-Allergan Breast Implant Recall |
||
04/23/19 | Risk Alert-Aid in Dying for Terminally Ill Act |
||
01/09/18 | Risk Alert-Infection Control Outbreak in Physician Offices |
Conventus Connection
Q2 2023 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q2 2023 Conventus Connection |
Q1 2023 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q1 2023 Conventus Connection |
Q1 2022 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q1 2022 Conventus Connection |
Q2 2022 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q2 2022 Conventus Connection |
Q3 2022 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q3 2022 Conventus Connection |
Q4 2022 Conventus Connection
Downloads:
Name | Format | Download |
---|---|---|
Q4 2022 Conventus Connection |
Spotlight
Date | Name | Format | Download |
---|---|---|---|
08/08/23 | Spotlight on BME Regulations: Conventus Member Benefits Aid in Meeting NJ Board CME Requirements |
||
07/31/23 | Spotlight on BME Regulations: Managing Sample Medications in Physician Offices |
||
04/14/23 | Spotlight on BME Regulations - A Patient’s Privacy Survives Their Passing |
||
03/22/23 | Spotlight on BME Regulations - Pain Management Series III: Assessment of Pain |
||
03/16/23 | Patient Safety Series Part III: Creating a Culture of Patient Safety in Your Practice |
||
03/02/23 | Spotlight on BME Regulations - Requirements for Prescribing Weight Loss Medications |
||
02/03/23 | Spotlight on BME Regulations - Pain Management Series Part II: Common Allegations Associated with Prescribing Pain Medication and Potential Risk Mitigation Strategies |
||
01/18/23 | Spotlight on BME Regulations - New Fees and Price Limits for Copies of Medical and Billing Records |
||
12/19/22 | Spotlight on BME Regulations: Review of the 2022 CDC Updated Clinical Practice Guideline for Prescribing Opioids |
||
12/12/22 | HIPAA Ensures a Patient’s Right to Request Changes to Medical Records |
||
11/29/22 | Patient Safety Series Part II: Reducing Risk Exposure through Standardized Process |
||
11/02/22 | Patient Safety Series - Part I: Why is Test Tracking and Follow-Up Important? |
||
09/29/22 | Spotlight on NJBME Regulations – Pain Management Series: Part I Overview |
||
08/23/22 | Spotlight on Cyber - Cybersecurity Tools: What You Need to Know |
||
07/07/22 | Spotlight on NJBME Regulations – Medical Assistants in Your Practice |
||
06/03/22 | Spotlight on NJBME Regulations – Regulatory Board Actions Defense for Conventus Members |
||
05/24/22 | Spotlight on Cyber - Risk Management Breach Solutions Resources |
||
05/17/22 | Spotlight on Cyber - What Does Your Cyber and Breach Response Coverage Include? |
||
05/05/22 | Spotlight on Cyber - How Conventus Can Help You Prevent and Respond to Data Security Threats |
||
03/24/22 | Spotlight on NJBME Regulations – Formal Agreements with Non-Physician Providers in Your Practice |
||
03/09/22 | Spotlight on NJBME Regulations – The Importance of Obtaining Informed Consent in Healthcare Settings |
||
01/16/22 | Spotlight on NJBME Regulations – Addressing Sexual Misconduct and The Presence of Chaperones |
Copyright and Disclaimer
Intellectual Rights and Copyright Statement:
This website and its contents are protected by the copyright laws of the United States. NIP Group, Inc (“NIP”) is the Attorney-in-Fact for Conventus Inter-Insurance Exchange (“Conventus”). NIP and Conventus (collectively referred to as the “Company”) has exclusive rights under U.S. and foreign copyright laws. The entirety of the content in this website is a collective work owned by the Company except as provided herein. Unless otherwise indicated, all materials and elements comprising this website, including without limitation, the content, text, website design, logos, graphics, icons, and images, as well as the selection, assembly and arrangement thereof are the sole property of the Company and its licensors, and are protected by U.S. and international copyright laws including protections available to The Company under the common law. All rights are reserved.
No materials on this website, either text or image, may be copied, reproduced, modified, uploaded, posted, transmitted, stored in a retrieval system or retransmission, or distributed in any way without prior written permission of the Company, except you may download materials designated by The Company for personal, non-commercial use only, provided all copyright and other proprietary notices are kept intact. The granting of this permission is not a transfer of title. Inclusion of any part of this website or any part of the materials in another work, whether in print, electronic or other form, and any inclusion of any part of the website or the materials in another website by linking, in-line linking to, framing or otherwise, is strictly prohibited.
Disclaimer:
The online Practice Resources and Knowledge Center content and information, including but not limited to any materials that are related to practice resources, practice management, practice management resources, risk management, patient safety or insurance regardless of where they are located on this website, are for educational purposes only. Materials provided on this website are intended solely to provide general information on a number of medical, legal, risk management, practice management, patient safety, practice resources and insurance issues. The Company takes reasonable efforts to provide accurate information but cannot guarantee its accuracy or that it meets local, state, or federal statutes, laws or regulations.
The Company disclaims any and all liability in respect to actions taken or not taken based on any or all the contents of this website. Information provided herein is not intended to constitute medical, legal, insurance or other professional advice. It is suggested that you consult with your legal counsel or other professional consultants about how the information pertains to your specific situation.
Although the Company makes reasonable efforts to provide accurate and reliable content, changes may be made to the information upon which the content is based. These changes may or may not be incorporated into the content of this website. The Company may amend the content of this website at any time, without notice. The Company may maintain archives of its previously published materials. Such materials may not be updated even if information changes. For example, content in the newsletters, risk alerts, toolkits, forms, applications, or any other information on the website may not be updated as rules, regulations, laws or statutes change, or if customary practices change.